SCHEMBL8177006

SCHEMBL8177006

COCOc1cccc(/C=C/C#Cc2ccc(C(=O)OC)cc2)c1-c1ccc(C)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 1/20 0.39
▸ TDP1 Q9NUW8 3/20 0.39
▸ SMN1; SMN2 Q16637 4/20 0.38
▸ RAB9A P51151 3/20 0.38
▸ NPC1 O15118 1/20 0.38
▸ LMNA P02545 6/20 0.37
▸ MAPT P10636 6/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP3A4 P08684 1/20 0.37
▸ CYP2C9 P11712 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ RARA P10276 2/20 0.37
▸ RARB P10826 2/20 0.37
▸ RARG P13631 2/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.36
▸ CHEK1 O14757 1/20 0.36
▸ AURKA O14965 1/20 0.36
▸ DAPK3 O43293 1/20 0.36
▸ JAK2 O60674 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1683989 0.92 RARB (0.45) EGFRTDP1SMN1; SMN2LMNAMAPT
SCHEMBL2941525 0.92 RARB (0.45) EGFRTDP1SMN1; SMN2LMNAMAPT
SCHEMBL8175733 0.89 TDP1 (0.43) TDP1SMN1; SMN2RAB9ANPC1LMNA
SCHEMBL8169474 0.86 EGFR (0.43) EGFRTDP1SMN1; SMN2RAB9ANPC1
SCHEMBL8175917 0.84 TDP1 (0.43) EGFRTDP1SMN1; SMN2RAB9ANPC1
SCHEMBL1683959 0.81 RARB (0.48) SMN1; SMN2RAB9ANPC1LMNAMAPT
SCHEMBL1683960 0.81 RARB (0.48) SMN1; SMN2RAB9ANPC1LMNAMAPT
SCHEMBL8174596 0.80 EGFR (0.41) EGFRTDP1SMN1; SMN2RAB9ANPC1
SCHEMBL8175984 0.80 EGFR (0.43) EGFRTDP1SMN1; SMN2RAB9ANPC1
SCHEMBL8167327 0.79 TDP1 (0.46) EGFRTDP1SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6150413-A TREATMENT OF DERMATOLOGICAL, RHEUMATIC, RESPIRATORY, CARDIOVASCULAR, BONE AND OPHTHALMOLOGICAL DISORDERS, AS WELL AS MAMMALIAN SKIN AND HAIR CONDITIONS; 4-(4-(BIPHENYL-2-YL)BUT-3-EN-1-YNYL)BENZOIC ACID, FOR EXAMPLE CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) 2000-11-21 — — US disclosed
Send feedback